Aridis Pharmaceuticals Inc. · OTC:ARDS
Armistice Capital, LLC reported a 6.63% stake in Aridis Pharmaceuticals Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Armistice Capital, LLC reported a 6.63% stake in Aridis Pharmaceuticals Inc., 703,557 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 6.63%
- Shares
- 703,557
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 6.63% | 703,557 |
| Steven Boyd | 6.63% | 703,557 |
Source
Related
- Aridis Pharmaceuticals Inc.
- Armistice Capital, LLC
- Aridis Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025